Compare LION & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LION | BHC |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2025 | 1996 |
| Metric | LION | BHC |
|---|---|---|
| Price | $10.39 | $5.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $10.06 | $8.33 |
| AVG Volume (30 Days) | 2.5M | ★ 2.5M |
| Earning Date | 05-04-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | $3,195,500,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | $22.98 | N/A |
| P/E Ratio | ★ N/A | $12.85 |
| Revenue Growth | ★ 7.00 | N/A |
| 52 Week Low | $5.65 | $4.28 |
| 52 Week High | $11.02 | $8.69 |
| Indicator | LION | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 33.15 |
| Support Level | $5.92 | N/A |
| Resistance Level | N/A | $7.22 |
| Average True Range (ATR) | 0.46 | 0.26 |
| MACD | 0.22 | -0.04 |
| Stochastic Oscillator | 77.97 | 20.76 |
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.